Iradimed IRMD
NASDAQ IRMD
$83.41 -0.99 (-1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Iradimed (IRMD) Operating Income Growth (1y) (2014 - 2026)

Analysis

Iradimed (IRMD) Operating Income Growth (1y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -17.50%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 30.74%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 22.08%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 49.06%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 43.83%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 24.81%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -95.55%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 49.72%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 16.18%
10 Iradimed 1.07 Bn 1.01 Bn 15.16 Mn -5.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.85%
Mar 31, 2026 33.23%
Dec 31, 2025 22.30%
Sep 30, 2025 18.04%
Jun 30, 2025 20.63%
Mar 31, 2025 14.40%
Dec 31, 2024 12.42%
Sep 30, 2024 -1.97%
Jun 30, 2024 13.38%
Mar 31, 2024 18.49%
Dec 31, 2023 21.30%
Sep 30, 2023 42.91%
Jun 30, 2023 19.12%
Mar 31, 2023 30.32%
Dec 31, 2022 36.80%
Sep 30, 2022 33.87%
Jun 30, 2022 125.93%
Mar 31, 2022 73.04%
Dec 31, 2021 377.64%
Sep 30, 2021 293.36%